Browse hierarchy: [Neurology (NE)](/submissions/NE) → [Subpart F — Physical Medicine Therapeutic Devices](/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices) → [21 CFR 890.5800](/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/890.5800) → QRA — Virtual Reality Behavioral Therapy Device For Pain Relief

# QRA · Virtual Reality Behavioral Therapy Device For Pain Relief

_Neurology · 21 CFR 890.5800 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/QRA

## Overview

- **Product Code:** QRA
- **Device Name:** Virtual Reality Behavioral Therapy Device For Pain Relief
- **Regulation:** [21 CFR 890.5800](/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/890.5800)
- **Device Class:** 2
- **Review Panel:** [Neurology](/submissions/NE)

## Identification

A virtual reality behavioral therapy device for pain relief is a device intended to provide behavioral therapy for patients with pain. Therapy is administered via a virtual reality display that utilizes a software program containing the behavioral therapy content.

## Classification Rationale

Class II (special controls). The special controls for this device are:

## Special Controls

*Classification.* Class II (special controls). The special controls for this device are:(1) Clinical performance testing under the labeled conditions for use must validate the model of behavioral therapy as implemented by the device and evaluate all adverse events.
(2) The patient-contacting components of the device must be demonstrated to be biocompatible.
(3) Software verification, validation, and hazard analysis must be performed.
(4) Electromagnetic compatibility and electrical, mechanical, and thermal safety testing must be performed.
(5) Labeling must include the following:
(i) A warning regarding the risk of nausea and motion sickness;
(ii) A warning regarding the risk of discomfort from the device; and
(iii) A summary of the clinical testing with the device.

## Recent Cleared Devices (6 of 6)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K254004](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/QRA/K254004.md) | VRNT | Cognifisense, Inc. | Apr 10, 2026 | SESE |
| [K251519](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/QRA/K251519.md) | RelieVRx (Pico G3) | Appliedvr | Aug 13, 2025 | SESE |
| [K243417](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/QRA/K243417.md) | RelieVRx | Appliedvr | Dec 4, 2024 | SESE |
| [K230814](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/QRA/K230814.md) | VRNT | Cognifisense, Inc. | Oct 31, 2023 | SESE |
| [K230825](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/QRA/K230825.md) | Smileyscope System (Therapy Mode) | Smileyscope Holding, Inc. | Sep 25, 2023 | SESE |
| [DEN210014](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/QRA/DEN210014.md) | EaseVRx | Appliedvr, Inc. | Nov 16, 2021 | DENG |

## Top Applicants

- Appliedvr — 2 clearances
- Cognifisense, Inc. — 2 clearances
- Appliedvr, Inc. — 1 clearance
- Smileyscope Holding, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/QRA](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/QRA)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com